Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Plant Health Care Plc | LSE:PHC | London | Ordinary Share | GB00B01JC540 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 8.925 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 8.925 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 21/8/2024 | 06:00 | UK RNS | AIM Cancellation - Plant Health Care plc |
| 20/8/2024 | 09:59 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI) |
| 20/8/2024 | 09:17 | UK RNS | Plant Health Care PLC Scheme of Arrangement becomes Effective |
| 20/8/2024 | 06:30 | UK RNS | AIM Suspension - Plant Health Care plc |
| 16/8/2024 | 09:14 | UK RNS | Plant Health Care PLC Exercise of Options & Rule 2.9 Announcement |
| 16/8/2024 | 08:13 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI) |
| 15/8/2024 | 21:01 | ALNC |  IN BRIEF: Plant Health Care acquisition by PI Industries approved |
| 15/8/2024 | 11:44 | UK RNS | Plant Health Care PLC Court sanction of the Scheme of Arrangement |
| 07/8/2024 | 17:02 | UK RNS | David Newlands Form 8.3 - Plant Health Care Plc |
| 07/8/2024 | 13:01 | UK RNS | Alexander Milne Form 8.3 - Plant Health Care plc |
Plant Health Care (PHC) Share Charts1 Year Plant Health Care Chart |
|
1 Month Plant Health Care Chart |
Intraday Plant Health Care Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 20/8/2024 | 07:20 | Plant Health Care; Using novel biological products in global markets | 881 |
| 16/7/2018 | 08:03 | PHC - 24p - MASSIVE BOWL ON CHART TO 120p | 101 |
| 10/8/2016 | 10:25 | Throw away the artificial Fertilizer with Plant Health Care | 408 |
| 15/3/2011 | 17:27 | Plant Health Care | 20 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 02/8/2024 15:35 by gb904150 These microcaps come with huge risk and yet when they finally get taken out it is at a minor premium to the share price, a price that has been diluted and destroyed over a period of 20 years.20 years of fundraises and PI's stumping up more money. Then, finally when all the work has been done, all the risk has been taken and 99% of value has been lost....that 1% of value turns into......2%! It's staggering really and makes a complete farce of the idea of investing in small cap shares. ISTM that PI Industries Ltd. are getting a steal. One of the few defences that PI's have got in this case is strong institutions or HNW's with large holdings who demand a decent premium. Yet in this case it just seems like everybody rolled over and was desperate to get their cash out. The buyout premium for these kinds of mega risk shares should be 4-5x the current share price But that kind of price will only be achieved if shareholders stand their ground. Just seems an absolute travesty this one. Didn't help all the BOD promises of breakeven and cash flow positive....followed by yet another placing. I don't think the BOD ever held much? I suspect that was part of the problem too. |
Posted at 02/8/2024 14:31 by 1pencil Cerrito by your own admission, why would you vote against something that is in your best financial interest ?US markets are in dire shape, PHC will likely need more cash to survive without the takeover. |
Posted at 02/6/2024 22:59 by pretax2 Thanks for your balanced comments Cerrito. There are always risks with small companies and PHC are no different; as you know.I agree, 25% is not a bad growth rate in normal times… however, with the destocking issue, growth went into reverse last year. So sub 25% growth this year building from a -5% baseline would not be so good, especially with so many new markets and products coming on stream for the company. It would suggest a very lukewarm reception for PHC products. I look at LinkedIn a lot (we all do) and the PHC field teams have worked tirelessly to promote the new product launches. There have been field trials, adverts, promotions as well as conference presentations. Early indications in 2024 are very positive. The company have growth milestones which they appear to take very seriously. That’s good, and in recent weeks I’ve started to rediscover my optimism. The shareprice recovery also suggests we’re striding forwards. All IMO. |
Posted at 31/5/2024 06:55 by pretax2 Final reporting date is actually the 28th June I believe. I get the feeling that the market for sustainable agrotech is getting rosier benefitting PHC. For example the EU are close to banning ‘forever’Farmers have to replace them with something - nudge - residue free peptides from PHC perhaps? As things improve I guess PHC will want to lace their 2023 FY reporting with positive forward statements. To be honest the 2023 FY lacks relevance today, given the temporary destocking blip is resolving. |
Posted at 21/5/2024 08:06 by fillipe A good start today at PHC.Looking forward to a further new geographical area of the world signing up for PHC product. f |
Posted at 20/4/2024 15:50 by cerrito Good question slicethepie as to when they get taken out.Industry players appear to have a different view of PHC prospects than Cavendish with their 42p target price and I am a bit uncomfortable that in all these months that the share price has been in the 3's that no-one has come on big to replace Mr Griffiths. My question mark and indeed concern is how Ispraie see this. I have no insight into their level of patience/requirement for liquidity nor indeed of their investors. The mind boggles as to what would happen to he share price if they followed-or tried to follow-Mr Griffiths to the exit door. |
Posted at 17/4/2024 06:45 by robsy2 I am trying to get my head around the investment case for this company so have PHC on my watchlist, am readingthe posts and research with interest.Lots of bumps in the road but the company seems to be making good progress and is about to become profitable yet the share price is at an all time low. With new distribution deals and approvals being announced, could be things are on the move? |
Posted at 07/4/2024 17:44 by pretax2 Hi CerritoNot sure how to interpret this (+ve or -ve) as far as PHC is concerned. 1/ "Indigo expanded into too many product areas": PHC have not - they've stuck with Harpin derived peptides. 2/ "Industry of slow adapters": Accepted; but environmental (and supermarket) policy is forcing growers to embrace sustainable growing techniques or lose market share. 3/ "Many of these agtech companies are not ‘tech’ companies, they are simply ‘tech enabled’". ['Tech enabled'?] Harpin is a scientific discovery which has been adapted and enhanced by PHC at its Seattle laboritory. All of the IP belongs to PHC. Somewhat paradoxically, Covid was 'initially' a good thing for PHC (distributors over-stocked), but now a bad thing with the current destocking. This out to be ending around about now so we can get back on the growth path. Time for an update. |
Posted at 26/4/2023 11:33 by pretax2 If you don’t mind me giving my own 2.5p worth.Both CR and JT have indicated that the share price should be higher. I asked CR why it was stagnating and he suggested that the company seemed to be viewed as a “show me” company. In other words show me that it works, show me that it sells, show me that you’re profitable. Up until last year I might have thought the same but things have fundamentally changed. PHC now has a suite of products; the products work brilliantly; revenue is growing towards profitability. But the big thing for me is climate change, energy change (biofuels), and a biblical food crisis. PHC have an answer for this - so the timing is right too. I guess all great companies start small and investors end up regretting they didn’t buy the shares way back “then” when the share price was peanuts. Well for PHC, this is the ‘peanuts’ 1.Profitability (especially if earlier than expected). 2. Takeover talk. PHC has destribution deals with a number of monster companies. There are also some interesting connections with Syngenta. 3/ Premise: The need for consolidation in the sector is well known and it’s starting to happen. Second, PHC is an American company keen to engage American investors. If you’ll forgive my fight of fancy, how about a reverse takeover of an American ag-tech company? If that happened hold onto your eyebrows, PHC shares would supernova. 4/ No reason at all. Many companies breakout from their doldrums for no apparent reason. There’s just a move to a more realistic value that gets bought into by traders. 5/ Press article. To me PHC has a really exciting story. The right article in the right journal at the right time and bingo. |
Posted at 19/1/2022 17:51 by cerrito Arden’s note on Research Tree a good summary pf the WE IMC meeting. It was good to hear that 279 will have a shelf life of 5 years; interested in the WE comment that these days a new product launch needs greater investment in time and effort than before and also that if a new product has not caught on after three years it never will.Good that Arden’s forecast has $4m of cash at the end of 22 with no equity raises forecast for 22. The PHC share price is suffering the same fate as my pre profit clean tech stocks such as CWR and ITM. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
